다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NYSE
KV Pharmaceutical Co. CL A (KV.A)
KV Pharmaceutical Co. CL A (KV.A) 뉴스

KV.A

K V Pharma (KV.A)

KV Pharmaceutical Co. CL A

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:KV.A

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2013/09/16	23:26	PR Newswire (US)	KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization	NYSE:KV.A	KV Pharmaceutical Co. CL A
2013/01/24	22:00	PR Newswire (US)	Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%...	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/12/29	02:43	PR Newswire (US)	K-V Pharmaceutical Receives Court Approval of Hologic Settlement	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/12/13	08:39	PR Newswire (US)	K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of P...	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/10	21:00	PR Newswire (US)	K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/09	00:09	PR Newswire (US)	K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/08	01:16	PR Newswire (US)	K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/06	20:57	PR Newswire (US)	K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC Markets	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/04	13:56	PR Newswire (US)	K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial Obligations	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/04	00:27	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/08/01	06:09	Edgar (US Regulatory)	Securities Registration Statement (S-1)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/27	05:27	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/21	05:05	PR Newswire (US)	K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing Criteria	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/14	05:43	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/07	05:21	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/04	04:35	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/07/02	22:15	PR Newswire (US)	FDA Issues Further Guidance About Makena®	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/30	07:51	PR Newswire (US)	K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing Criteria	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/23	05:32	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/21	05:19	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/19	05:36	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/18	22:14	PR Newswire (US)	FDA and CMS Issue Important Updates on Makena®	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/06/08	06:12	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/26	05:15	PR Newswire (US)	K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market Activity	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	06:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	06:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	04:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	04:45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	04:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A
2012/05/17	04:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:KV.A	KV Pharmaceutical Co. CL A

검색 관련기사 보기:NYSE:KV.A

1 2 3 4 5 6 7 8 9 10 다음 >>

Energy Select Sector SPDR

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Financial Select Sector

US Dollar vs Euro

Gold vs US Dollar

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관